ctrl K

Price Alert

Aurinia Pharmaceuticals I... (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

12.02

-0.20 (-1.64%)

At close: Aug 19, 2025, 3:59 PM

12.03

0.08%

After-hours: Aug 19, 2025, 04:10 PM EDT

Aurinia Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	83.43M	48.88M	94.17M	231.9M
Short-Term Investments	275.04M	301.61M	295.22M	234.18M
Long-Term Investments	n/a	201K	n/a	n/a
Other Long-Term Assets	823K	1.52M	13.34M	11.84M
Receivables	36.54M	24.09M	13.48M	15.41M
Inventory	39.23M	39.7M	24.75M	19.33M
Other Current Assets	1.13M	1.03M	1.33M	796K
Total Current Assets	446.6M	424.8M	442.54M	513.32M
Property-Plant & Equipment	98.87M	116.57M	8.56M	9.8M
Goodwill & Intangibles	4.36M	4.98M	6.42M	8.4M
Total Long-Term Assets	104.05M	123.26M	28.32M	30.04M
Total Assets	550.64M	548.06M	470.86M	543.37M
Account Payables	5.19M	4.33M	3.09M	3.88M
Deferred Revenue	11M	4.81M	3.15M	31.07M
Short-Term Debt	15.07M	26.91M	936K	1.06M
Other Current Liabilities	66.5M	29.3M	17.22M	16.41M
Total Current Liabilities	97.76M	77.19M	46.11M	40.65M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	11.11M	10.91M	12.17M	15.95M
Total Long-Term Liabilities	75.4M	92.92M	19.32M	23.63M
Total Liabilities	173.17M	170.11M	65.42M	64.28M
Total Debt	79.37M	97.61M	8.09M	8.74M
Common Stock	1.19B	1.2B	1.19B	1.18B
Retained Earnings	-936.57M	-942.32M	-864.3M	-756.12M
Comprehensive Income	-647K	-730K	-1.06M	-852K
Shareholders Equity	377.48M	377.95M	405.44M	479.09M
Total Investments	275.04M	301.81M	295.22M	234.18M